drugset / Trial / NCT00154700
Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to find out the response rate of twice weekly paclitaxel and cisplatin and weekly HDFL in recurrent or metastatic esophageal carcinoma patients who need palliative Chemotherapy.
Timeline
- Start
- 2001-01
- Primary completion
- —
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Paclitaxel | Small molecule | — | — |
| Subject | fluorouracil | Small molecule | — | — |
| Subject | folic acid | Other / unclassified | — | — |